BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4818050)

  • 1. Modification of experimental myocardial infarct size by cardiac drugs.
    Puri PS
    Am J Cardiol; 1974 Apr; 33(4):521-8. PubMed ID: 4818050
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamic studies in aortic regurgitation.
    Kloster FE; Bristow JD; Lewis RP; Griswold HE
    Am J Cardiol; 1967 May; 19(5):644-52. PubMed ID: 6023460
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute myocardial infarction in man. Comparative hemodynamic effects of norepinephrine and glucagon.
    Diamond G; Forrester J; Danzig R; Parmley WW; Swan HJ
    Am J Cardiol; 1971 Jun; 27(6):612-6. PubMed ID: 5092474
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of ischemic injury by nitroglycerin during acute myocardial infarction.
    Epstein SE; Kent KM; Goldstein RE; Borer JS; Redwood DR
    N Engl J Med; 1975 Jan; 292(1):29-35. PubMed ID: 803223
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
    Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
    Circulation; 1972 Feb; 45(2):335-51. PubMed ID: 5009478
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of isoproterenol and norepinephrine on myocardial function in experimental cardiogenic shock.
    Cronin RF
    Am Heart J; 1967 Sep; 74(3):387-95. PubMed ID: 6041067
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of norepinephrine and isoproterenol in experimental coronary shock. Observations on the effects of dextran infusion.
    Fearon RE
    Am Heart J; 1968 May; 75(5):634-48. PubMed ID: 5645989
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of isoproterenol on hemodynamic alterations, myocardial metabolism, and coronary flow in experimental acute myocardial infarction with shock.
    Kuhn LA; Kline HJ; Goodman P; Johnson CD; Marano AJ
    Am Heart J; 1969 Jun; 77(6):772-83. PubMed ID: 5770150
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental myocardial infarction. X. Efficacy of glucagon in acute and healing phase in intact conscious dogs: effects on hemodynamics and myocardial oxygen consumption.
    Kumar R; Molokhia FA; Norman JC; Inamdar AN; Messer JV; Abelmann WH; Hood WB; Sharma GV
    Circulation; 1972 Jan; 45(1):55-64. PubMed ID: 5007038
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol.
    Mueller H; Ayres SM; Gregory JJ; Giannelli S; Grace WJ
    J Clin Invest; 1970 Oct; 49(10):1885-902. PubMed ID: 5460498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitroglycerin-induced reduction in the incidence of spontaneous ventricular fibrillation during coronary occlusion in dogs.
    Borer JS; Kent KM; Goldstein RE; Epstein SE
    Am J Cardiol; 1974 Apr; 33(4):517-20. PubMed ID: 4206443
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of isoproterenol and 1-norepinephrine on function, coronary flow, and oxygen consumption of the intact left ventricle.
    Abe T; Malik AB; O'Kane HO; Geha AS
    Surgery; 1973 Oct; 74(4):562-9. PubMed ID: 4729221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influencing of the circulation rate and oxygen metabolism in the ischemic myocardium. Comparison with the effect on the normal myocardium].
    Parrat JR; Marshall RJ; Ledingham IM
    Med Welt; 1974 Jul; 25(26):1152-5. PubMed ID: 4152465
    [No Abstract]   [Full Text] [Related]  

  • 14. Preservation of ischemic myocardium.
    Forrester JS; Chatterjee K
    Adv Cardiol; 1974; 11(00):158-0. PubMed ID: 4415185
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Circulation; 1976 Mar; 53(3 Suppl):I162-8. PubMed ID: 767015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic agents and infarct size. Theoretical and practical considerations.
    Lesch M
    Am J Cardiol; 1976 Mar; 37(4):508-13. PubMed ID: 1258787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of norepinephrine and digitalis on myocardial oxygen consumption in the newborn lamb.
    Downing SE; Lee JC; Taylor JF; Halloran K
    Circ Res; 1973 Apr; 32(4):471-9. PubMed ID: 4702041
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac performance and metabolism in shock due to acute myocardial infarction in man: response to catecholomines and mechanical cardiac assist.
    Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
    Trans N Y Acad Sci; 1972 Apr; 34(4):309-33. PubMed ID: 4502562
    [No Abstract]   [Full Text] [Related]  

  • 19. Newer concepts in the pathophysiology of ischemic heart disease.
    Kirk ES; Sonnenblick EH
    Am Heart J; 1982 Apr; 103(4 Pt 2):756-67. PubMed ID: 7064809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of isoproterenol, l-norepinephrine, and glucagon on myocardial gas tensions in animals with coronary artery stenosis.
    Furuse A; Brawley RK; Gott VL
    J Thorac Cardiovasc Surg; 1973 May; 65(5):815-24. PubMed ID: 4696881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.